Analysis of the Human Prostate-Specific Proteome Defined by Transcriptomics and Antibody-Based Profiling Identifies TMEM79 and ACOXL as Two Putative, Diagnostic Markers in Prostate Cancer
2015 (English)In: PLoS ONE, ISSN 1932-6203, Vol. 10, no 8, e0133449Article in journal (Refereed) Published
To better understand prostate function and disease, it is important to define and explore the molecular constituents that signify the prostate gland. The aim of this study was to define the prostate specific transcriptome and proteome, in comparison to 26 other human tissues. Deep sequencing of mRNA (RNA-seq) and immunohistochemistry-based protein profiling were combined to identify prostate specific gene expression patterns and to explore tissue biomarkers for potential clinical use in prostate cancer diagnostics. We identified 203 genes with elevated expression in the prostate, 22 of which showed more than five-fold higher expression levels compared to all other tissue types. In addition to previously well-known proteins we identified two poorly characterized proteins, TMEM79 and ACOXL, with potential to differentiate between benign and cancerous prostatic glands in tissue biopsies. In conclusion, we have applied a genome-wide analysis to identify the prostate specific proteome using transcriptomics and antibody-based protein profiling to identify genes with elevated expression in the prostate. Our data provides a starting point for further functional studies to explore the molecular repertoire of normal and diseased prostate including potential prostate cancer markers such as TMEM79 and ACOXL.
Place, publisher, year, edition, pages
2015. Vol. 10, no 8, e0133449
IdentifiersURN: urn:nbn:se:kth:diva-173148DOI: 10.1371/journal.pone.0133449ISI: 000358942400012PubMedID: 26237329OAI: oai:DiVA.org:kth-173148DiVA: diva2:854789
FunderKnut and Alice Wallenberg FoundationSwedish Cancer Society
QC 201509172015-09-172015-09-072015-09-17Bibliographically approved